Upload
doandiep
View
213
Download
0
Embed Size (px)
Citation preview
Page 1 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
July 13, 2015
Dear Provider:
At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made to the WellCare’s South Carolina Medicaid Preferred Drug List (PDL), effective August 15, 2015. Please carefully review these changes.
Key UPPER CASE = Brand Name Drugs QL = Quantity Limit
Lower case italics = Generic Drugs ST = Step Therapy
PDL = Preferred Drug List AL = Age Limit PA = Prior Authorization YOA = Years of Age
Effective date of change: August 15, 2015
Drug Name Therapeutic Class Change PDL Alternative
(if applicable)
ADDITIONS TO THE PDL
acetaminophen 650 mg suppositories
Analgesics - Nonnarcotic
Added to the PDL
aminophylline 25
mg/mL solution
Antiasthmatic And
Bronchodilator Agents
Added to the PDL
amphetamine-dextroamphetamine
extended-release capsules - all
strengths
ADHD/Anti-
Narcolepsy/Anti-Obesity/Anorexiants
Added to the PDL w/ QL (62
capsules/31 days) & AL: Min 6 YOA,
Max 20 YOA
apap 325 mg tablets Analgesics - Nonnarcotic
Added to the PDL
argyle sterile 0.9%
irrigation saline solution
Genitourinary
Agents - Miscellaneous
Added to the PDL
aspirin 81 mg enteric coated
tablets
Analgesics -
Nonnarcotic Added to the PDL
bismuth subsalicylate 262
mg/15 mL suspension
Antidiarrheals Added to the PDL
calcium Minerals & Added to the PDL
UPDATE WellCare’s South Carolina
Preferred Drug List
Page 2 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
carbonate/vitamin d 600 mg-400 unit
tablets
Electrolytes
Drug Name Therapeutic Class Change/Reason
for Change
PDL Alternative (if
applicable)
clozapine 12.5 mg orally disintegrating tablets
Antipsychotics/Antimanic Agents
Added to the PDL
w/ QL (31 tablets/31 days) &
AL: Min 18 YOA
delsym night time cough/cold 12.5-5 mg/5 mL liquid
Cough/Cold/Allergy Added to the PDL
delsym night time cough/cold 6.25-2.5 mg/5 mL liquid
Cough/Cold/Allergy Added to the PDL
DILANTIN 30 mg capsules
Anticonvulsants
Added to the PDL
w/ QL: 310 capsules/31 days
duloxetine 20 mg,
60 mg capsules Antidepressants
Added to the PDL
w/ QL (62 capsules/31 days) & ST (trial of
preferred SSRI, gabapentin,
amitriptyline, or venlafaxine).
duloxetine 30 mg
capsules Antidepressants
Added to the PDL w/ QL (31
capsules/31 days) & ST (trial of
preferred SSRI, gabapentin, amitriptyline, or
venlafaxine).
fentanyl 37.5 mcg, 62.5 mcg, 87.5 mcg
patches
Analgesics - Opioid Added to the PDL w/ PA & QL (10
patches/30 days)
IN-CHECK dial flow trainer device
Medical Devices Added to the PDL
KALYDECO 50 mg,
75 mg granules
Respiratory Agents -
Misc.
Added to the PDL
w/ PA
lidocaine-prilocaine 2.5-2.5% kit
Dermatologicals Added to the PDL
lithium carbonate Antipsychotics/Anti Added to the PDL
Page 3 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
150 mg, 600 mg capsules
manic Agents
Drug Name Therapeutic Class Change/Reason
for Change
PDL Alternative (if
applicable)
melatonin maximum strength 5 mg
tablets
Alternative
Medicines Added to the PDL
methylphenidate hydrochloride
chewable tablets - all strengths
ADHD/Anti-Narcolepsy/Anti-
Obesity/Anorexiants
Added to the PDL
w/ AL: Min 6 YOA
morphine sulfate
preservative free 2 mg/mL, 4 mg/mL injection
Analgesics - Opioid Added to the PDL
multivitamin/fluoride
0.25 mg chewable tablets
Multivitamins Added to the PDL
naproxen enteric
coated 500 mg tablets
Analgesics - Anti-
Inflammatory Added to the PDL
norethindrone & ethinyl estradiol-fe
0.8 mg-25 mcg chewable tablets
Contraceptives Added to the PDL
ONCASPAR 750 mg/mL injection
Antineoplastics and
Adjunctive Therapies
Added to the PDL w/ PA
oticin 1-0.1% otic
liquid Otic Agents Added to the PDL
oyster shell calcium/D 250 mg-125 unit tablets
Minerals & Electrolytes
Added to the PDL
phenytoin 50 mg chewable tablets
Anticonvulsants Added to the PDL w/ QL: 372 tablets/31 days
prenatal low iron 27-
0.8 mg tablets Multivitamins Added to the PDL
risperidone tablets -
all strengths
Antipsychotics/Anti
manic Agents
Added to the PDL w/ QL (62
tablets/31 days) & AL: Min 5 YOA
Drug Name Therapeutic Class Change/Reason
for Change
PDL Alternative (if
applicable)
Page 4 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
rizatriptan 5 mg, 10
mg tablets Migraine Products
Added to the PDL w/ AL: Min 6
YOA, Max 17 YOA
SANTYL 250
unit/gm ointment Dermatologicals Added to the PDL
slow release iron 160 (50 fe) mg
extended-release tablets
Hematopoietic
Agents Added to the PDL
tamoxifen 10 mg
tablets
Antineoplastics and Adjunctive
Therapies
Added to the PDL
trinate tablets Multivitamins Added to the PDL
vitamin b complex-c capsules
Multivitamins Added to the PDL
ZUBSOLV 8.6 mg-
2.1 mg sublingual tablets
Analgesics - Opioid Added to the PDL w/ PA
UTILIZATION MANAGEMENT CHANGES
ALKERAN 2 mg tablets
Antineoplastics and
Adjunctive Therapies
Added PA
butalbital-asa-
caffeine oral capsule 50-325-40
mg
Analgesics -
Nonnarcotic Removed QL
citalopram tablets -
all strengths Antidepressants Removed QL
dextroamphetamine extended-release
capsules - all strengths
ADHD/Anti-
Narcolepsy/Anti-Obesity/Anorexiants
Updated QL: 31
capsules/31 days
EMCYT 140 mg
capsules
Antineoplastics and
Adjunctive Therapies
Added PA
enoxaparin sodium injections - all
strengths
Anticoagulants
Updated QL: 300 mg/3 mL: QL: 93
mL/31 days 100 mg/mL: QL: 31 mL/31 days
150 mg/mL: QL: 31 mL/31 days 120 mg/0.8 mL: QL:
Page 5 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
24.8 mL/31 days 80 mg/0.8 mL: QL:
24.8 mL/31 days 30 mg/0.3 mL: QL: 9.3 mL/31 days
40 mg/0.4 mL: QL: 12.4 mL/31 days 60 mg/0.6 mL: QL:
18.6 mL/31 days
Drug Name Therapeutic Class Change/Reason
for Change
PDL Alternative (if
applicable)
etoposide 50 mg
capsules
Antineoplastics and
Adjunctive Therapies
Added PA
GABITRIL 12 mg,
16 mg tablets Anticonvulsants Removed AL
INVEGA SUSTENNA
injection
Antipsychotics/Antimanic Agents
Updated QL : 117 mg/0.75 mL: QL:
0.75 mL/28 days 156 mg/mL: QL: 1 mL/28 days
234 mg/1.5 mL: QL: 1.5 mL/28 days 39 mg/0.25 mL: QL:
0.25 mL/28 days 78 mg/0.5 mL: QL: 0.5 mL/28 days
LEUKERAN 2 mg tablets
Antineoplastics and
Adjunctive Therapies
Added PA
LOMUSTINE
capsules - all strengths
Antineoplastics and
Adjunctive Therapies
Added PA
loxapine 5 mg
capsules
Antipsychotics/Anti
manic Agents
Added AL: Min 18
YOA
LYSODREN 500 mg
tablets
Antineoplastics and Adjunctive
Therapies
Added PA
methylphenidate 10 mg extended-
release tablets
ADHD/Anti-Narcolepsy/Anti-
Obesity/Anorexiants
Added AL Max:
Max 20 YOA
methylphenidate tablets - all
strengths
ADHD/Anti-Narcolepsy/Anti-
Obesity/Anorexiants
Remove AL Max
MYLERAN 2 mg tablets
Antineoplastics and Adjunctive Therapies
Added PA
Page 6 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
nicotine polacrilex 2
mg, 4 mg mint gum
Psychotherapeutic And Neurological
Agents - Misc.
Updated QL: 2016 pieces/365
days
Drug Name Therapeutic Class Change/Reason
for Change
PDL Alternative (if
applicable)
oxcarbazepine 600 mg tablets
Anticonvulsants Removed QL
PEG-3350
ELECTROL 236 gm, 240 gm solution
Laxatives QL added: 4,000 mL/31 days
risperidone 1 mg/mL solution
Antipsychotics/Antimanic Agents
Updated QL &
Added AL: QL:496 mL/31 days, AL: Min 5
YOA
SAPHRIS 5 mg, 10 mg sublingual
tablets
Antipsychotics/Anti
manic agents
Updated AL: Min
10 YOA
spinosad 0.9% topical suspension
Dermatologicals Updated AL: Min 6 months of age
sumatriptan succinate 6 mg/0.5
mL solution for injection
Migraine Products Updated QL: 4
injections/31 days
TABLOID 40 mg
tablets
Antineoplastics and Adjunctive
Therapies
Added PA
thioridazine 100 mg
tablets
Antipsychotics/Anti
manic Agents
Added AL: Min 2
YOA
REMOVALS FROM THE PDL
ACETAMIN 80 mg/0.8 mL infant
drops
Analgesics -
Nonnarcotic
Removed from
PDL
Please reference PDL
acetasol hydrocortisone 2-1%
otic solution
Otic Agents Removed from PDL
Please reference PDL
ACIDOPHILUS PROBIOTIC tablets
Laxatives Removed from PDL
Please reference PDL
ACIDOPHILUS wafer
Laxatives Removed from PDL
Please reference PDL
Page 7 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
ACIDOPHILUS/BIFI
DUS wafer Laxatives
Removed from
PDL
Please reference PDL
Acidophilus/Pectin
capsules Laxatives
Removed from
PDL
Please reference PDL
acitretin 17.5 mg
capsules Dermatologicals
Removed from
PDL
Please reference PDL
acne wash 2 %
liquid Dermatologicals
Removed from
PDL
Please reference PDL
ADDERALL XR capsules - all strengths
ADHD/Anti-Narcolepsy/Anti-Obesity/Anorexiants
Removed from PDL
amphetamine/dextroamphetamine
extended-release capsules - all
strengths (QL, AL may apply)
ADRUCIL 500
mg/10mL injection
Antineoplastics and
Adjunctive Therapies
Removed from
PDL
fluorouracil 500
mg/10ml solution
AFRIN 0.05% nasal
spray solution
Nasal Agents - Systemic And
Topical
Removed from
PDL
Please reference PDL
ALTARYL 12.5 mg/5
mL syrup Antihistamines
Removed from
PDL
Please reference PDL
AMITIZA 8 mcg, 24
mcg capsules
Gastrointestinal
Agents - Misc.
Removed from
PDL
lactulose oral solution;
polyethylene glycol
antifungal 1 %
aerosol Dermatologicals
Removed from
PDL
Please reference PDL
artificial tears 83-15
% ophthalmic ointment
Ophthalmic Agents Removed from
PDL
Please reference PDL
artificial tears 0.1-0.3 % ophthalmic
solution
Ophthalmic Agents Removed from
PDL
Please reference PDL
b complex 50 tablets Multivitamins Removed from PDL
Please reference PDL
baby d-drops 400 unit/0.03 mL liquid
Vitamins Removed from PDL
Please reference PDL
Page 8 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
benzoyl peroxide 10%, 5% liquid
wash
Dermatologicals Removed from
PDL Please reference PDL
benzoyl peroxide 6
% cleanser lotion Dermatologicals
Removed from
PDL Please reference PDL
beta care cream,
lotion Dermatologicals
Removed from
PDL Please reference PDL
BP 10-1% emulsion Dermatologicals Removed from
PDL Please reference PDL
BP 2.5 % liquid
wash Dermatologicals
Removed from
PDL Please reference PDL
BP 4 % cleansing
lotion Dermatologicals
Removed from
PDL
Please reference PDL
calamine 8-8 %
lotion Dermatologicals
Removed from
PDL
Please reference PDL
calamine lotion Dermatologicals Removed from
PDL
Please reference PDL
calamine
phenolated lotion Dermatologicals
Removed from
PDL
Please reference PDL
calcitrate 315-250
mg-unit tablets
Minerals &
Electrolytes
Removed from
PDL
Please reference PDL
calcitriol 3 mcg/gm
ointment Dermatologicals
Removed from
PDL
Please reference PDL
calcium 1200-1200-1000 mg-unit
chewable tablets
Minerals &
Electrolytes
Removed from
PDL
Please reference PDL
calcium 500 + d 500-125 mg-unit
tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
calcium 600 + minerals 600-200 mg-unit tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
calcium 600+d 600-200 mg-unit tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
calcium 600+d plus minerals 600-400 mg-unit chewable
tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
Page 9 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
calcium 600+d plus minerals 600-400
mg-unit tablets
Minerals &
Electrolytes
Removed from
PDL
Please reference PDL
calcium 600-1500
mg tablets
Minerals &
Electrolytes
Removed from
PDL
Please reference PDL
calcium citrate 200
mg tablets
Minerals &
Electrolytes
Removed from
PDL
Please reference PDL
calcium-carbonate 600 + d 600-125
mg-unit tablets
Minerals &
Electrolytes
Removed from
PDL
Please reference PDL
calcium-magnesium-zinc 333-133-5 mg
tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
calcium-vitamin d 600-200 mg-unit tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
cetaphil liquid Dermatologicals Removed from PDL
Please reference PDL
chewable calcium 500-200-40 mg-unt-mcg chewable
tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
children's complete allergy 12.5 mg
chewable tablets
Antihistamines Removed from PDL
Please reference PDL
childrens silfedrine 15 mg/5mL liquid
Nasal Agents - Systemic And Topical
Removed from PDL
Please reference PDL
citranatal dha 27-1 & 250 mg pak
Multivitamins Removed from PDL
Please reference PDL
citranatal rx 27-1 mg tablets
Multivitamins Removed from PDL
Please reference PDL
clemastine fumarate 0.67 mg/5 mL syrup
Antihistamines Removed from PDL
Please reference PDL
colloidal oatmeal bath packet
Dermatologicals Removed from PDL
Please reference PDL
complete natal dha
29-1-200 & 250 mg pak
Multivitamins Removed from PDL
Please reference PDL
Page 10 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
condoms Medical Devices Removed from
PDL Please reference PDL
COPEGUS 200 mg tablets
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For
Service PDL for specifics
CORDRAN 4
mcg/sqcm tape Dermatologicals
Removed from
PDL Please reference PDL
dermaphor ointment Dermatologicals Removed from
PDL
Please reference PDL
dexamethasone
sodium phosphate preservative free 10
mg/mL injection
Corticosteroids Removed from PDL
dexamethasone
sodium phosphate injection
solution 10 mg/ml
DIFF-STAT chewables
Laxatives Removed from PDL
Please reference PDL
diltiazem
hydrochloride 100 mg reconstituted solution intravenous
Calcium Channel Blockers
Removed from PDL
diltiazem hcl intravenous
solution 125 mg/25ml, 25 mg/5ml, 50
mg/10ml
diphenhydramine
12.5 mg/5 mL elixir Antihistamines
Removed from
PDL Please reference PDL
domeboro packet Dermatologicals Removed from
PDL Please reference PDL
doxycycline monohydrate 100
mg tablets
Tetracyclines Removed from PDL
doxycycline monohydrate 100
mg capsules
ENDOMETRIN 100 mg suppositories
Vaginal Products Removed from PDL
progesterone 100 mg capsules
etoposide 500 mg/25 mL injection
Antineoplastics and Adjunctive Therapies
Removed from PDL
EURAX 10% cream, lotion
Dermatologicals Removed from PDL
permethrin external lotion 1 %; permethrin
Page 11 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
external cream 5 %
exemestane 25 mg
tablets
Antineoplastics and Adjunctive
Therapies
Removed from
PDL
anastrozole oral
tablet
eye drops advanced relief 0.05-0.1-1-1 %
ophthalmic solution
Ophthalmic Agents Removed from
PDL
Please reference PDL
fareston 60 mg tablets
Antineoplastics and Adjunctive
Therapies
Removed from PDL
tamoxifen 10 mg tablets
FIBER THERAPY 500 mg tablets
Laxatives Removed from PDL
Please reference PDL
FLORANEX chewables
Laxatives Removed from PDL
Please reference PDL
flutamide 125 mg capsules
Antineoplastics and Adjunctive Therapies
Removed from PDL
FORMULA EM 1.87-1.87-21.5 solution
Antiemetics Removed from PDL
Please reference PDL
GAVILYTE-C SOL 60/15 mL stool softener syrup
Laxatives Removed from PDL
Please reference PDL
GENERESS FE chewable tablets
Contraceptives Removed from PDL
norethindrone &
ethinyl estradiol-fe 0.8 mg-25 mcg
chewable tablets
genteal 0.25-0.3 % ophthalmic gel
Ophthalmic Agents Removed from PDL
Please reference PDL
genteal mild 0.2 % ophthalmic solution
Ophthalmic Agents Removed from PDL
Please reference PDL
genteal mild to moderate 0.3 % ophthalmic solution
Ophthalmic Agents Removed from PDL
Please reference PDL
genteal severe 0.3 % ophthalmic gel
Ophthalmic Agents Removed from PDL
Please reference PDL
glycerin 2 gm, 2.1 gm suppositories
Laxatives Removed from PDL
Please reference PDL
Page 12 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
glycerin liquid Dermatologicals Removed from
PDL Please reference PDL
GNP capsaicin 0.1
% cream Dermatologicals
Removed from
PDL
Please reference PDL
goniovisc 2.5 %
ophthalmic solution Ophthalmic Agents
Removed from
PDL Please reference PDL
haloperidol 20 mg
tablets
Antipsychotics/Anti
manic Agents
Removed from
PDL
haloperidol oral
tablet 10 mg
HARVONI 90-400 mg tablets
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For
Service PDL for specifics
hemorrhoidal 0.25-
3-14-71.9 % ointment
Anorectal Agents Removed from
PDL
Please reference PDL
hemorrhoidal 0.25-3-85.5 %
suppository
Anorectal Agents Removed from
PDL
Please reference PDL
homatropine hydrobromide 5 %
ophthalmic solution
Ophthalmic Agents Removed from PDL
atropine sulfate ophthalmic
solution
hydrocortisone-aloe 0.5%, 1% cream
Dermatologicals Removed from PDL
Please reference PDL
INCIVEK 375 mg tablets
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For Service PDL for
specifics
INFERGEN
injections - all strengths
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For Service PDL for
specifics
INSPIREASE bags, mouthpiece
Medical Devices Removed from PDL
Please reference PDL
Page 13 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
invisible acne treatment 10 %
cream
Dermatologicals Removed from
PDL
Please reference PDL
KALA tablets Laxatives Removed from
PDL
Please reference PDL
KLOR-CON 20 meq,
25 meq packets
Minerals &
Electrolytes
Removed from
PDL
KLOR-CON oral
tablets; potassium
chloride oral
solution 20meq/15ml (10%)
lactobacillus tablets, packets, wafers
Antidiarrheals Removed from PDL
Please reference PDL
LAXATIVE
W/SENNA 25 mg tablets
Laxatives Removed from PDL
Please reference PDL
leuprolide 1 mg/0.2 mL injection
Antineoplastics and
Adjunctive Therapies
Removed from PDL
LICE KILLING
maximum strength 0.33-4% shampoo
Dermatologicals Removed from
PDL
spinosad 0.9%
topical suspension
lice treatment 0.33-4
% liquid Dermatologicals
Removed from
PDL
spinosad 0.9% topical
suspension
lice treatment 1 %
liquid Dermatologicals
Removed from
PDL
spinosad 0.9% topical
suspension
loperamide-simethicone 2-125
mg tablets
Antidiarrheals Removed from PDL
Please reference PDL
lubricant eye drops 0.4-0.3 % ophthalmic solution
Ophthalmic Agents Removed from PDL
Please reference PDL
lubricating plus eye
drops 0.5 % ophthalmic solution
Ophthalmic Agents Removed from PDL
Please reference PDL
LUPRON-DEPOT
injection - all strengths
Antineoplastics and
Adjunctive Therapies
Removed from PDL
TRELSTAR suspension
magnesium citrate
1.745 gm/30mL solution
Laxatives Removed from
PDL Please reference PDL
Page 14 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
methyldopate hydrochloride 250
mg/5 mL solution
Antihypertensives Removed from
PDL
METHYLIN
chewable tablets - all strengths
ADHD/Anti-
Narcolepsy/Anti-Obesity/Anorexiants
Removed from
PDL
methylphenidate hcl chewable tabs
- all strengths (AL may apply)
metronidazole 0.75
% gel Dermatologicals
Removed from
PDL
metronidazole
external 1 %
MINERAL OIL
ENEMA Laxatives
Removed from
PDL Please reference PDL
MODERIBA pak - all strengths
Antivirals Removed from PDL
Hepatitis C drugs
are now covered by the state. Refer to Fee For
Service PDL for specifics
muscle relief 0.075 % cream
Dermatologicals Removed from PDL
Please reference PDL
naproxen sodium
220 mg tablets
Analgesics - Anti-
Inflammatory
Removed from
PDL
naproxen oral
tablet 250 mg, 375 mg, 500 mg
nasal decongestant
10 mg tablets
Nasal Agents -
Systemic And Topical
Removed from
PDL Please reference PDL
natures tears 0.4 %
ophthalmic solution Ophthalmic Agents
Removed from
PDL Please reference PDL
NATURL FIBER
68% powder Laxatives
Removed from
PDL Please reference PDL
NIACIN er 250 mg extended-release
tablets
Vitamins Removed from
PDL
no flush niacin
oral tablet 500 mg
NORDITROPIN flexpro solution - all
strengths
Endocrine And Metabolic Agents -
Misc.
Removed from
PDL
OMNITROPE subcutaneous
solution (PA applies)
OLYSIO 150 mg capsules
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For
Service PDL for specifics
Page 15 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
ORAL SALINE
laxative solution Laxatives
Removed from
PDL Please reference PDL
oyst-cal d 250-125
mg-unit tablets
Minerals &
Electrolytes
Removed from
PDL Please reference PDL
oyster shell calcium +D 500 mg-400U
tablets
Minerals &
Electrolytes
Removed from
PDL Please reference PDL
oyster shell calcium 250+d 250-125 mg-
unit tablets
Minerals &
Electrolytes
Removed from
PDL Please reference PDL
oyster shell calcium/d 500-200
mgunit tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
PAIN & FEVER 80 mg chewables
Analgesics - Nonnarcotic
Removed from PDL
Please reference PDL
parva-cal 500-200 mg-unit tablets
Minerals & Electrolytes
Removed from PDL
Please reference PDL
PEDIA-LAX 1 gm suppositories
Laxatives Removed from PDL
Please reference PDL
PEGASYS kit,
injection, proclick Antivirals
Removed from
PDL
Hepatitis C drugs are now covered by the state.
Refer to Fee For Service PDL for
specifics
PEG-INTRON kit - all strengths
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For Service PDL for
specifics
phenazo 95 mg tablets
Genitourinary Agents -
Miscellaneous
Removed from PDL
phenazopyridine hcl oral tablet 100
mg, 200 mg
polyvitamin/iron chewable tablets
Multivitamins Removed from PDL
Please reference PDL
potassium bicarbonate 25 meq
effervescent tablets
Minerals &
Electrolytes
Removed from
PDL
potassium chloride crys er oral tablet
extendedrelease 10 meq, 20 meq
Page 16 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
potassium citrate 5 meq (540 mg)
extended-release tablets
Genitourinary
Agents - Miscellaneous
Removed from
PDL
cytra-2 oral
solution
pr natal 400 29-1-200 & 400 mg pak
Multivitamins Removed from PDL
Please reference PDL
pr natal 430 29-1-200 & 430 mg pak
Multivitamins Removed from PDL
Please reference PDL
pr natal 430 ec 29-
1-200 & 430 mg (dr) pak
Multivitamins Removed from PDL
Please reference PDL
PROBIOTIC DAILY
capsules Laxatives
Removed from
PDL
Please reference PDL
promethazine 25
mg/mL injection Antihistamines
Removed from
PDL
promethazine
hydrochloride 50 mg/mL solution injection
Antihistamines Removed from PDL
PROMETHEGAN SUPPOSITORY 12.5
MG Antihistamines
Removed from PDL
promethazine hcl
suppository 25 mg
PSYLDEX 30% powder
Laxatives Removed from PDL
Please reference PDL
pyrethins-piperonyl
butoxide 0.2-2 % liquid
Dermatologicals Removed from PDL
Please reference PDL
QC NATURAL
VEGETABLE powder
Laxatives Removed from
PDL
Please reference PDL
RA aspirin 500 mg
tablets
Analgesics -
Nonnarcotic
Removed from
PDL
Please reference PDL
RA COL-RITE
50MG capsules Laxatives
Removed from
PDL
Please reference PDL
ra hemorrhoidal 0.25-3-12-18 %
cream
Anorectal Agents Removed from
PDL
Please reference PDL
REBETOL • 40 mg/mL solution
• 200 mg capsules
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state.
Page 17 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
Refer to Fee For Service PDL for
specifics
REBETRON kit - all strengths
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For
Service PDL for specifics
REGONOL 5 mg/mL
injection
Antimyasthenic/Chol
inergic Agents
Removed from
PDL
renal 1 mg
capsules Multivitamins
Removed from
PDL Please reference PDL
ribavirin 500 mg tablets
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For
Service PDL for specifics
salivasure mouth/throat
lozenges
Mouth/Throat/Dental
Agents
Removed from
PDL Please reference PDL
SB FIB LAX 33%
powder Laxatives
Removed from
PDL Please reference PDL
sb lice treatment
0.3-3 % liquid Dermatologicals
Removed from
PDL
spinosad 0.9% topical
suspension
select-ob 29-1 mg chewable tablets
Multivitamins Removed from PDL
Please reference PDL
sf 5000 plus 1.1 % dental cream
Mouth/Throat/Dental Agents
Removed from PDL
PHOS-FLUR DENTAL 1.1 %
sirolimus 1 mg, 2 mg tablets
Assorted Classes Removed from PDL
tacrolimus oral capsule 0.5 mg, 1
mg, 5 mg
sm ibuprofen 100 mg junior tablets, chewables
Analgesics - Anti-Inflammatory
Removed from PDL
Please reference PDL
SMOOTH LAX 3350 NF powder packets
Laxatives Removed from PDL
Please reference PDL
Page 18 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
sodium chloride (hypertonic) 5%
ophthalmic solution
Ophthalmic Agents Removed from
PDL Please reference PDL
SOVALDI 400 mg tablets
Antivirals Removed from PDL
Hepatitis C drugs are now covered
by the state. Refer to Fee For
Service PDL for specifics
SUDAFED-12 12 hr* 120 mg
extended-release tablets
Nasal Agents -
Systemic And Topical
Removed from
PDL
Please reference PDL
sulfacetamide
sodium- sulfur 10-5% cream, lotion
Dermatologicals Removed from
PDL
sulfacetamide
sodium external suspension 10 %
tears again
ophthalmic ointment Ophthalmic Agents
Removed from
PDL Please reference PDL
tolnaftate 1 %
solution Dermatologicals
Removed from
PDL Please reference PDL
TUCKS 51%
suppository Anorectal Agents
Removed from
PDL Please reference PDL
UNIVERT 32 mg
tablets Antiemetics
Removed from
PDL Please reference PDL
verapamil
hydrochloride 2.5 mg/mL solution injection
Calcium Channel Blockers
Removed from PDL
VICTRELIS 200 mg
capsules Antivirals
Removed from
PDL
Hepatitis C drugs
are now covered by the state.
Refer to Fee For Service PDL for specifics
VIEKIRA pak tablets Antivirals Removed from
PDL
Hepatitis C drugs
are now covered by the state.
Refer to Fee For Service PDL for specifics
vitamin a 10,000 unit tablets
Vitamins Removed from PDL
Please reference PDL
Page 19 of 19
SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14
vitamin a 25,000
unit capsules Vitamins
Removed from
PDL Please reference PDL
vitamin a palmitate
15,000 unit tablets Vitamins
Removed from
PDL Please reference PDL
vitamin c 500 mg extended-release
tablets
Vitamins Removed from
PDL Please reference PDL
vitamin c 500
mg/5mL liquid Vitamins
Removed from
PDL Please reference PDL
vitamin c tablet 1000
MG ORAL; vitamin c
tablet 100 MG
Vitamins Removed from
PDL
Please reference PDL
vitamin D 400 unit capsules
Vitamins Removed from PDL
Please reference PDL
vitamin d3 2,000 unit super strength
tablets
Vitamins Removed from PDL
Please reference PDL
vitamin d3 50,000 unit capsules
Vitamins Removed from PDL
Please reference PDL
vitatrum chewable tablets
Multivitamins Removed from PDL
Please reference PDL
zinc 25 mg tablets Minerals & Electrolytes
Removed from PDL
Please reference PDL
ZYTIGA 250 mg tablets
Antineoplastics and Adjunctive Therapies
Removed from PDL
If you have questions, WellCare’s Pharmacy Help Desk and its affiliated vendor, Catamaran, are available to assist providers at 1-888-588-9842.
Thank you for your care of WellCare’s South Carolina Medicaid members. Sincerely,
WellCare Health Plans, Inc.